148 related articles for article (PubMed ID: 22594558)
1. Cost effectiveness of interferon-gamma release assay for school-based tuberculosis screening.
Kowada A
Mol Diagn Ther; 2012 Jun; 16(3):181-90. PubMed ID: 22594558
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of the interferon-γ release assay for tuberculosis screening of hemodialysis patients.
Kowada A
Nephrol Dial Transplant; 2013 Mar; 28(3):682-8. PubMed ID: 23239835
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
Kowada A; Takasaki J; Kobayashi N
J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of high resolution computed tomography with interferon-gamma release assay for tuberculosis contact investigation.
Kowada A
Eur J Radiol; 2013 Aug; 82(8):1353-8. PubMed ID: 23489981
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan.
Kowada A; Takahashi O; Shimbo T; Ohde S; Tokuda Y; Fukui T
Mol Diagn Ther; 2008; 12(4):235-51. PubMed ID: 18652520
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of interferon-gamma release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations.
Kowada A; Deshpande GA; Takahashi O; Shimbo T; Fukui T
Mol Diagn Ther; 2010 Aug; 14(4):229-36. PubMed ID: 20799765
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes.
Kowada A
Epidemiol Infect; 2016 Nov; 144(15):3215-3225. PubMed ID: 27412626
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of interferon-γ release assay for TB screening of HIV positive pregnant women in low TB incidence countries.
Kowada A
J Infect; 2014 Jan; 68(1):32-42. PubMed ID: 23973660
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries.
Kowada A
Travel Med Infect Dis; 2016; 14(5):489-498. PubMed ID: 27238907
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke.
Kowada A
Int J Tuberc Lung Dis; 2015 Jul; 19(7):857-63. PubMed ID: 26056114
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of interferon-γ release assay versus chest X-ray for tuberculosis screening of employees.
Kowada A
Am J Infect Control; 2011 Dec; 39(10):e67-72. PubMed ID: 21839543
[TBL] [Abstract][Full Text] [Related]
12. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-α antagonist therapy.
Kowada A
Mol Diagn Ther; 2010 Dec; 14(6):367-73. PubMed ID: 21275454
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective.
Kowada A
J Infect; 2019 Jan; 78(1):58-65. PubMed ID: 30009853
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany.
Diel R; Nienhaus A; Loddenkemper R
Chest; 2007 May; 131(5):1424-34. PubMed ID: 17494792
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of interferon-gamma release assay for entry tuberculosis screening in prisons.
Kowada A
Epidemiol Infect; 2013 Oct; 141(10):2224-34. PubMed ID: 23286364
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.
del Campo MT; Fouad H; Solís-Bravo MM; Sánchez-Uriz MA; Mahíllo-Fernández I; Esteban J
Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1226-34. PubMed ID: 23143360
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of QuantiFERON testing before initiation of biological therapy in inflammatory bowel disease.
Swaminath A; Bhadelia N; Wang YC
Inflamm Bowel Dis; 2013 Oct; 19(11):2444-9. PubMed ID: 23945184
[TBL] [Abstract][Full Text] [Related]
20. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
